Arkolith/Insider Trading/QNCX/Form 4

Hannah Brendan

CBO, COO & CCOQuince Therapeutics, Inc. (QNCX) · full profile →Form 4 · filed Jun 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2025Grant(A)38K$1.20$45K334K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 18, 2025Grant(A)38K$0.13$5K38K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000912282-25-000697) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML